These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 138478)

  • 21. [Disruption of DNA synthesis and structure of mouse L1210 leukemia cells, sensitive and resistant to 1-methyl-1 nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in vivo].
    Kukushkina GV; Peretolchina NM; Minenkova EA; Verovskiĭ VN; Sof'ina ZP
    Biokhimiia; 1984 Jul; 49(7):1189-98. PubMed ID: 6477985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA repeat length in chromatin from murine bone marrow and L1210 leukaemia cells.
    Dean SW; Tew KD; Clark AE; Schein PS
    Br J Cancer; 1985 Sep; 52(3):377-82. PubMed ID: 2931097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of N,N'-bis(2-chloroethyl)-N-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-2-deoxy-D-glucopyranose upon the proliferation, DNA synthesis, and viability of cultured sensitive and resistant L1210 cells.
    Wheeler GP; Alexander JA; Adamson DJ
    Cancer Res; 1980 Oct; 40(10):3723-7. PubMed ID: 6449283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative effect of administration schedules on the antitumor activities of 3 water-soluble nitrosoureas, ACNU, GANU and MCNU against L1210 leukemia].
    Kato T; Ota K
    Gan To Kagaku Ryoho; 1983 May; 10(5):1354-62. PubMed ID: 6223585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity.
    Fujimoto S; Ogawa M
    Cancer Chemother Pharmacol; 1982; 9(3):134-9. PubMed ID: 6218931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea on experimental tumors.
    Hisamatsu T; Uchida S
    Gan; 1977 Dec; 68(6):819-24. PubMed ID: 202535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical and clinical studies on chlorozotocin, a new nitrosourea with decreased bone marrow toxicity.
    Macdonald JS; Hoth D; Schein PS
    Recent Results Cancer Res; 1980; 70():83-9. PubMed ID: 6444466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA damage and repair in L1210 cells exposed to 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Hilton J; Bowie DL; Gutin PH; Zito DM; Walker MD
    Cancer Res; 1977 Jul; 37(7 Pt 1):2262-6. PubMed ID: 861950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity of human and murine hematopoietic precursor cells to 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Schein PS; Bull JM; Doukas D; Hoth D
    Cancer Res; 1978 Feb; 38(2):257-60. PubMed ID: 620400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo study of acute hematotoxicity of three nitrosoureas, chlorozotocin (chloro-2-ethyl)-ribofuranosyl-3-nitrosourea, and (chloro-2-ethyl)-1-ribopyranosyl-3-nitrosourea.
    Mori KJ; Jasmin C; Hayat M; MacDonald JS; Mathé G
    Cancer Res; 1980 Nov; 40(11):4282-6. PubMed ID: 6451285
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of biochemical and biological effects of four nitrosoureas with differing carbamoylating activities.
    Kann HE
    Cancer Res; 1978 Aug; 38(8):2363-6. PubMed ID: 149589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contributions of nitrosoureas to cancer treatment.
    Mitchell EP; Schein PS
    Cancer Treat Rep; 1986 Jan; 70(1):31-41. PubMed ID: 3002621
    [No Abstract]   [Full Text] [Related]  

  • 33. Antitumor effects of GANU and other nitrosourea derivatives against transplantable leukemias and solid tumors in mice.
    Sava G; Giraldi T
    Cancer Chemother Pharmacol; 1983; 10(3):167-9. PubMed ID: 6222844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L-Chlorozotocin.
    Johnston TP; McCaleb GS; Anderson T; Murinson DS
    J Med Chem; 1979 May; 22(5):597-9. PubMed ID: 156793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An analysis of 1-(2-chloroethyl)-1-nitrosourea activity at the cellular level.
    Weinkam RJ; Dolan ME
    J Med Chem; 1983 Nov; 26(11):1656-9. PubMed ID: 6226795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition and recovery of DNA synthesis in host tissues and sensitive and resistant B16 melanoma after 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea, a predictor of therapeutic efficacy.
    Brereton HD; Bryant TL; Young RC
    Cancer Res; 1975 Sep; 35(9):2420-5. PubMed ID: 1149044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
    Mulcahy RT; Siemann DW
    Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of mechanism of action studies of the nitrosoureas.
    Bono VH
    Cancer Treat Rep; 1976 Jun; 60(6):699-702. PubMed ID: 182364
    [No Abstract]   [Full Text] [Related]  

  • 39. Toxicological study on a new nitrosourea derivative, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea.
    Fujimoto S; Ogawa M
    Jpn J Cancer Res; 1985 Jul; 76(7):651-6. PubMed ID: 3928562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of experimental studies on nitrosourea derivatives in Japan.
    Tsukagoshi S
    Recent Results Cancer Res; 1980; 70():107-17. PubMed ID: 7355242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.